贞芪扶正胶囊、克林霉素联合小剂量复方新诺明治疗非HIV感染的肺孢子菌肺炎的临床疗效观察-现代医学

贞芪扶正胶囊、克林霉素联合小剂量复方新诺明治疗非HIV感染的肺孢子菌肺炎的临床疗效观察

单位：上海市杨思医院呼吸内科, 上海 200126

关键词：贞芪扶正胶囊克林霉素复方新诺明非人类免疫缺陷病毒感染肺孢子菌肺炎临床疗效

分类号：R563.19

出版年·卷·期（页码）：2018·46·第一期（34-38）

摘要：

目的：探讨贞芪扶正胶囊、克林霉素联合小剂量复方新诺明治疗非人类免疫缺陷病毒（HIV）感染的肺孢子菌肺炎（NH-PCP）的临床效果。方法：将本院收治的93例NH-PCP患者随机分为对照组（n=46）和联合用药组（n=47），对照组给予常规剂量的复方新诺明治疗，联合用药组采用贞芪扶正胶囊、克林霉素联合小剂量复方新诺明治疗，比较两组治疗前后血常规指标、血氧指标、相关血清生物标志物、免疫功能指标水平，并对两组临床疗效和不良反应发生情况进行比较。结果：联合用药组治疗后血常规指标中淋巴细胞数（LYM）和白蛋白（ALB）、血氧指标、相关血清生物标志物及免疫功能指标水平均显著优于对照组（P<0.05）；临床治疗总有效率联合用药组显著高于对照组（91.49%vs.76.09%，χ²=4.077，P=0.043），且治疗期间不良反应发生率联合用药组显著低于对照组（P<0.05）。结论：采用贞芪扶正胶囊、克林霉素联合小剂量复方新诺明治疗NH-PCP能显著提高临床疗效，且安全性较好，值得在临床上推广应用。

Objective:To study the clinical effect of Zhenqi Fuzheng capsules, clindamycin combined with low-dose compound sulfamethoxazole in the treatment of non-HIV-infected pneumocystis pneumonia (NH-PCP). Methods:Nity-three cases of NH-PCP treated in our hospital were randomly divided into the control group (n=46) and the combined medication group (n=47).The control group was treated with conventional-dose compound sulfamethoxazole and the combined medication group was treated with Zhenqi Fuzheng capsules,clindamycin and low-dose compound sulfamethoxazole.Blood routine indexes,blood oxygen indexes, related serum biomarkers and immune function indexes were detected and compared between the two groups before and after treatment. The clinical efficacy and the adverse reactions of the two groups was compared. Results:The levels of lymphocyte count (LYM)and albumin (ALB) in the blood routine indexes, blood oxygen indexes,related serum biomarkers and immune function indexes in the combined medication group were significantly better than those in the control group (P<0.05).The total effective rate of the combined medication group was significantly higher that of the control group (91.49% vs.76.09%,χ²=4.077,P=0.043).The incidence of adverse reactions in the combined medication group was significantly lower than that of the control group (P<0.05). Conclusions:Zhenqi Fuzheng capsules,clindamycin combined with low-dose compound sulfamethoxazole in the treatment of NH-PCP can significantly improve the clinical efficacy,promote LYM,ALB and blood oxygen indexes,improve related serum biomarkers and immune function.It is safe and worthy of clinical application.

参考文献：

[1] 曾健生,钱素云.肺孢子菌肺炎的诊断与治疗[J].中华实用儿科临床杂志,2012,27(18):1453-1456.
[2] 李晓亮,马希涛.肺孢子菌肺炎研究进展[J].中华实用诊断与治疗杂志,2014,28(11):1049-1051.
[3] BIENVENU A L,TRAORE K,PLEKHANOVA I,et al.Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patients[J].Int J Infect Dis,2016,46:11-17.
[4] TASAKA S,TOKUDA H.Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies[J].J Infect Chemother,2012,18(6):793-806.
[5] 徐丽婷,李欢欢,张娟红,等.卡氏肺孢子菌肺炎药物治疗研究进展[J].兰州大学学报:医学版,2017,43(2):66-71.
[6] CHANG H M,TSAI H C,LEE S S,et al.High daily doses of trimethoprim/sulfamethoxazole are an independent risk factor for adverse reactions in patients with pneumocystis pneumonia and AIDS[J].J Chin Med Assoc,2016,79(6):314-319.
[7] 陈钟,肖钢,周泉,等.克林霉素联合复方磺胺甲口恶唑片治疗艾滋病合并肺孢子菌肺炎的疗效分析[J].中国感染控制杂志,2016,15(10):773-776.
[8] LI H,HUANG H,HE H.Successful treatment of severe Pneumocystis pneumonia in an immunosuppressed patient using caspofungin combined with clindamycin:a case report and literature review[J].BMC Pulm Med,2016,16(1):144.
[9] 中华医学会呼吸病学分会感染学组.肺真菌病诊断和治疗专家共识[J].中华结核和呼吸杂志,2007,30(11):821-834.
[10] 魏月霞,相巧丽,姚彦芬,等.卡泊芬净联合胸腺肽及小剂量复方新诺明治疗肺孢子菌肺炎25例体会[J].临床合理用药,2015,8(10A):162-163.
[11] LI M C,LEE N Y,LEE C C,et al.Pneumocystis jiroveci pneumonia in immunocompromised patients:Delayed diagnosis and poor outcomes in non-HIV-infected individuals[J].J Microbiol Immunol Infect,2014,47(1):42-47.
[12] NAKASHIMA K,AOSHIMA M,NAKASHITA T,et al.Low-dose trimethoprim-sulfamethoxazole treatment for pneumocystis pneumonia in non-human immunocompromised patients:A single-center retrospective observational cohort study[J].J Microbiol Immunol Infect,2017:in press.
[13] 张燕,许小凤,陈翊,等.贞芪扶正胶囊联合化疗对中晚期宫颈癌患者的疗效及免疫功能影响[J].现代生物医学进展,2016,16(36):7117-7120.
[14] SALERNO D,MUSHATT D,MYERS L,et al.Serum and bal beta-D-glucan for the diagnosis of Pneumocystis pneumonia in HIV positive patients[J].Respir Med,2014,108(11):1688-1695.
[15] 叶宁,朱明利,李茜茜,等.肺孢子菌肺炎实验室诊断研究进展[J].中国卫生检验杂志,2017,27(4):604-605.
[16] LI Y,GHANNOUM M,DENG C,et al.Pneumocystis pneumonia in patients with inflammatory or autoimmune diseases:Usefulness of lymphocyte subtyping[J].Int J Infect Dis,2017,57:108-115.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录